國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Atlas of clinical PET-CT in treatmen...

Carrio, Ignasi.

Atlas of clinical PET-CT in treatment response evaluation in oncology

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Atlas of clinical PET-CT in treatment response evaluation in oncologyedited by Stefano Fanti, Gopinath Gnanasegaran, Ignasi Carrio.
其他作者:	Fanti, Stefano.
出版者:	Cham :Springer International Publishing :2021.
面頁冊數:	xiii, 488 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	CancerCase studiesTomography
電子資源:	https://doi.org/10.1007/978-3-030-68858-5
ISBN:	9783030688585$q(electronic bk.)

Atlas of clinical PET-CT in treatment response evaluation in oncology
Atlas of clinical PET-CT in treatment response evaluation in oncology[electronic resource] /edited by Stefano Fanti, Gopinath Gnanasegaran, Ignasi Carrio. - Cham :Springer International Publishing :2021. - xiii, 488 p. :ill., digital ;24 cm.

PART I General Chapters: Introduction to Treatment response evaluation: Science and Practice -- CT in Treatment response evaluation - Overview -- MRI & Diffusion weighted MRI in Treatment response evaluation- Overview -- PET & PET-CT in Treatment response evaluation-Overview -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in post-surgical setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in chemotherapy setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in radiation oncology -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in Immunotherapy settings -- Treatment response evaluation of bone metastases using 18F-NaF -- How to report PET-CT scans in post therapy scenarios: Do's and don'ts -- PART II Atlas Articles: 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Head and neck cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in lung cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in neuro-oncology -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in hepatobiliary cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gastroesophageal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Lymphoma and Non-hodgkins lymphoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in breast cancer -- 18F-FDG, 18F-Choline & 68Ga-PSMA PET-CT in Treatment response evaluation in prostate cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gynaecological cancers -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in colorectal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in soft tissue sarcomas -- FDG & Non FDG PET-CT in Treatment response evaluation in malignant melanoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in myeloma -- FDG PET-CT & 18F-NaF in Treatment response evaluation in bone metastases and bone tumours -- 18F-FDG & Non FDG PET-CT in Assessment of treatment response in paediatric oncology -- 68Ga-DOTA PET-CT in Treatment response evaluation in NETs -- 18F-DOPA PET-CT in Treatment response evaluation -- 18F-FLT PET-CT in Treatment response evaluation -- Brain PET-CT in Treatment response evaluation.

This text atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods.

ISBN: 9783030688585$q(electronic bk.)

Standard No.: 10.1007/978-3-030-68858-5doiSubjects--Topical Terms:

727000
Cancer
--Tomography--Case studies

LC Class. No.: RC270.3.T65 / A75 2021

Dewey Class. No.: 616.9940757

Atlas of clinical PET-CT in treatment response evaluation in oncology
LDR:04594nmm a2200325 a 4500 001 602595
003 DE-He213
005 20210708134451.0
006 m d
007 cr nn 008maaau
008 211112s2021 sz s 0 eng d
020 $a 9783030688585$q(electronic bk.)
020 $a 9783030688578$q(paper)
024 7 $a 10.1007/978-3-030-68858-5 $2 doi
035 $a 978-3-030-68858-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.3.T65 $b A75 2021
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKR $2 thema
082 0 4 $a 616.9940757 $2 23
090 $a RC270.3.T65 $b A881 2021
245 0 0 $a Atlas of clinical PET-CT in treatment response evaluation in oncology $h [electronic resource] / $c edited by Stefano Fanti, Gopinath Gnanasegaran, Ignasi Carrio.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xiii, 488 p. : $b ill., digital ; $c 24 cm.
505 0 $a PART I General Chapters: Introduction to Treatment response evaluation: Science and Practice -- CT in Treatment response evaluation - Overview -- MRI & Diffusion weighted MRI in Treatment response evaluation- Overview -- PET & PET-CT in Treatment response evaluation-Overview -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in post-surgical setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in chemotherapy setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in radiation oncology -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in Immunotherapy settings -- Treatment response evaluation of bone metastases using 18F-NaF -- How to report PET-CT scans in post therapy scenarios: Do's and don'ts -- PART II Atlas Articles: 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Head and neck cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in lung cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in neuro-oncology -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in hepatobiliary cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gastroesophageal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Lymphoma and Non-hodgkins lymphoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in breast cancer -- 18F-FDG, 18F-Choline & 68Ga-PSMA PET-CT in Treatment response evaluation in prostate cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gynaecological cancers -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in colorectal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in soft tissue sarcomas -- FDG & Non FDG PET-CT in Treatment response evaluation in malignant melanoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in myeloma -- FDG PET-CT & 18F-NaF in Treatment response evaluation in bone metastases and bone tumours -- 18F-FDG & Non FDG PET-CT in Assessment of treatment response in paediatric oncology -- 68Ga-DOTA PET-CT in Treatment response evaluation in NETs -- 18F-DOPA PET-CT in Treatment response evaluation -- 18F-FLT PET-CT in Treatment response evaluation -- Brain PET-CT in Treatment response evaluation.
520 $a This text atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods.
650 0 $a Cancer $x Tomography $v Case studies $v Atlases. $3 727000
650 0 $a Tomography, Emission $v Congresses. $3 446801
650 1 4 $a Nuclear Medicine. $3 275838
650 2 4 $a Oncology. $3 195181
700 1 $a Fanti, Stefano. $3 338217
700 1 $a Gnanasegaran, Gopinath. $3 593489
700 1 $a Carrio, Ignasi. $3 678206
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-68858-5
950 $a Medicine (SpringerNature-11650)